Polyherbal Formulation of Persea americana, Curcuma zedoaria, Syzygium polyanthum, Morinda citrifolia, and Andrographis paniculata for Diabetes: an In Vitro and In Vivo Analysis
Abstract
Diabetes mellitus (DM) is a complex chronic metabolic condition characterized by elevated blood glucose levels that necessitates multi-targeted therapeutic strategies. Previous studies have demonstrated antidiabetic properties of Persea americana leaves (PAL), Curcuma zedoaria rhizome (CZR), Syzygium polyanthum leaves (SPL), Morinda citrifolia leaves (MCL), and Andrographis paniculata herba (APH) through α-glucosidase, α-amylase, and PTP1B inhibition, as well as glucose uptake enhancement. This research aimed to evaluate antioxidant and antidiabetic activities of polyherbal formulation (PF) consisting of PAL, CZR, SPL, MCL, and APH in a 3:3:2:1:1 ratio through in vitro radical scavenging assay and carbohydrate-digesting enzyme inhibition. In vivo assessment was carried out in alloxan-induced diabetic mice and evaluated blood glucose levels, endogenous antioxidant levels, DPP-4 inhibition, and pancreas histopathology. The results indicated that PF exhibited strong antioxidant capacity with DPPH and ABTS IC50 values of 76.78 ± 1.31 µg/mL and 36.32 ± 1.40 µg/mL, respectively. PF also showed an α-glucosidase IC50 of 9.24 ± 1.68 µg/mL, which was significantly lower than the positive control (p < 0.05) and moderate α-amylase inhibition, with IC50 of 105.90 ± 1.72 µg/mL. The In vivo experiment indicated that PF reduced blood glucose levels only by 16.94%, an effect mediated through DPP-4 inhibition. PF administration had no significant effect on SOD and MDA levels (p > 0.05). However, PF improved pancreatic histopathology and reduced signs of necrosis. Despite its promising in vitro antioxidant and antidiabetic activity, the effect was not translated to the in vivo system.